We found significant improvements for cancer-related fatigue in the intervention group ( baseline mean SD 5.95 1.701 , end-of-study mean 3.8 1.542 , p = 0.001 , reduction of 36 % ) compared to the control group ( baseline mean 4.95 0.999 , end-of-study mean unchanged at 5.0 1.556 , p = 0.887 ) ; as well as for emotional and social functioning scales and physical performance ( p < 0.05 ) .